论文部分内容阅读
Background Assuming the serious situations due to extensive drug-resistant acinetobacter baumannii (XDR A.baumannii) ventilator-associated pneumonia (VAP) as a considerable unmet medical need, this study may help to get new scientific evidence of tigecycline in a shorter time in order to improve our patients clinical outcome.